Showing results (1711-1720 of 2,008) with videos related to
Sort By:
Pageof 201
European Review for Medical and Pharmacological Sciences|July 4, 2023
Partial cellular reprogramming stably restores the stemness of senescent epidermal stem cellsY-R Su, S-M Gu, Y-R Liu, et al.JCI Insight|August 25, 2022
In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathiesChang Li, Aphrodite Georgakopoulou, Gregory A Newby, et al.Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|December 28, 2021
[Efficacy of Han-uvulopalatopharyngoplasty (HUPPP) combined with radiofrequency ablation of tongue base or HUPPP with traction of tongue base on moderate to severe patients with obstructive sleep apnea hypopnea syndrome (OSAHS):a multicenter randomized controlled trial]W W Yu, H M Zhu, H H Xu, et al.Nature Biotechnology|May 4, 2023
Efficient prime editing in mouse brain, liver and heart with dual AAVsJessie R Davis, Samagya Banskota, Jonathan M Levy, et al.Zhonghua Yi Xue Za Zhi|March 12, 2026
[Association between long-term cumulative levels of non-high-density lipoprotein cholesterol and the risk of cardiovascular disease: a prospective cohort study]W J Ma, F C Liu, C Shen, et al.Genes, Brain, and Behavior|January 10, 2018
Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathiesP Zhou, N He, J-W Zhang, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing <i>in vivo</i>Han Zhang, Karen Kelly, Jonathan Lee, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 24, 2023
[A phase I study of subcutaneous envafolimab (KN035) monotherapy in Chinese patients with advanced solid tumors]R R Liu, S Z Gu, T Zhou, et al.[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|August 8, 2023
[Distribution and reference intervals of daytime intraocular pressure in the eye health screening population of Handan]Y Q Yang, S J Fan, A G Lyu, et al.Scientific Reports|January 13, 2015
Systematic review and meta-analysis of the survival outcomes of first-line treatment options in high-risk prostate cancerJun H Lei, Liang R Liu, Qiang Wei, et al.Pageof 201